乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Critical Care >

Myocardial Infarction

News, opinions and meeting coverage in critical care.

<乌鸦传媒>CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Underpowered IMPRESS trial shows no mortality benefit

<乌鸦传媒>ESC: DES or BMS? No Mortality Difference

After 6 years, death was as likely in DES patients as in BMS patients

<乌鸦传媒>EuroPCR: Staged Stenting Undermines SYNTAX II Strategy

Practice of unnecessary "re-touching" in the cath lab needs to go

<乌鸦传媒>Survival Rates Good With VAD for Complicated Acute MI

Despite being sicker to start, outcomes on par with other VAD patients

<乌鸦传媒>ACC: No Benefit for Beta-Blocker Before PCI

IV metoprolol was safe, but disappointing

<乌鸦传媒>CNN Calls Out 'Cataract Risk' in HOPE-3

Statins and cataracts: So what?

<乌鸦传媒>CardoBrief: The Vulnerable Plaque 'Hype-othesis'

A requiem for vulnerable plaque

<乌鸦传媒>Early Risk Period Seen for Survivors of Cardiogenic Shock

In-hospital mortality declining but a vulnerable time follows for rehospitalization, studies say

<乌鸦传媒>PA Home Visits Save $$ After Cardiac Surgery

Physician assistant house calls cut unnecessary post-op readmissions

<乌鸦传媒>Stent for MI Linked to Subsequent Surgery Risks

More evidence supporting waiting period for noncardiac surgery

<乌鸦传媒>FDA Lifts Restriction On Rosiglitazone

Agency sees no need for restrictions after easing them 2 years ago

<乌鸦传媒>CardioBrief: 'Walking Time Bombs'

Is this fear mongering or effective communication of risk?

<乌鸦传媒>Is SAMHSA to Blame for a Broken Mental Health System?

Two members of Congress differ on how to fix a failing system

<乌鸦传媒>Safety Warning: Watch LVAD Battery Expiration

Ventricular support backup battery issue linked to two deaths

<乌鸦传媒>Guidelines Issued for Managing Temperature During CBP

Clinicians now have officially sanctioned procedures to follow

<乌鸦传媒>Testosterone Shots: Riskier Than Gels or Patches?

Spike in T levels from bolus injections may explain higher adverse outcome rates.

<乌鸦传媒>TECOS Top Line: No Increase in CV Risk with DPP-4 Inhibitor

Primary and secondary endpoints met for those on sitagliptin.

<乌鸦传媒>ACC: Folate Supplements Cut Strokes in Hypertension

Hypertensive patients with low blood folate levels gain big benefit.

<乌鸦传媒>Morning Break: Penis Reduction? Patient Suffering

Health news and commentary from around the Web, gathered by the 乌鸦传媒 staff.

<乌鸦传媒>CardioBuzz: Why Patients Don鈥檛 Take Heart Meds

Faced with patients' instinctive aversion to pills, even after MI, what's a cardiologist to do?

<乌鸦传媒>ESC: Will CvLPRIT Change Practice?

BARCELONA -- Cardiologists react to findings from the CvLPRIT study, which challenge not only traditional thinking but also existing guidelines from both the U.S. and Europe, all of which say that treating nonculprit arteries in STEMI patients may be harmful.

<乌鸦传媒>The Day My Brother Became a Statistic

My brother would have turned 37 today. Instead, he became a statistic in 1995.

<乌鸦传媒>CardioBuzz: Is Marijuana Bad for Your Heart?

Whether marijuana actually causes cardiovascular problems remains unclear, a situation that was not necessarily helped by a study based on 35 reports of cannabis-related complications in France, a country with about 1.2 million recreational users.

<乌鸦传媒>How To Get Medicare To Cover A Spa Trip

Good news for doctors who think their patients need a trip to the spa: Medicare will reimburse, with only two catches.

<乌鸦传媒>How to Replace IV Nitroglycerin in the Shortage

What are the alternatives for IV nitroglycerin in the emergency setting as the shortage saps reserves? Several experts share their thoughts.

<乌鸦传媒>ACC: Metformin No Help in MI Recovery

WASHINGTON -- Metformin started soon after reperfusion in the acute setting didn't help cardiac function recover in nondiabetic heart attack patients, a trial showed.

<乌鸦传媒>Top 5 Reasons Cardiologists Get Sued

Problems with diagnosis -- failing to make one, making the wrong one, or taking too long to get to one -- lead the list of reasons behind cardiology-related lawsuits, revealed closed claims data from a medical malpractice insurer.

<乌鸦传媒>Is There a Flaw in This Large Vitamin D Trial?

A co-principal investigator of the VITAL trial addresses the possibility that out-of-study testing of vitamin D levels and initiation of high-dose supplementation could be a limitation, but not a serious one.

<乌鸦传媒>Heart Attack Signal Found for Spiriva in COPD

The TIOSPIR trial was used to support safety of the mist inhaler version of tiotropium (Spiriva) compared with dry powder, but the pooled data actually showed something else -- a heart attack signal, researchers argued.

<乌鸦传媒>CardioBuzz: More Money Needed for Heart Research?

The NIH dedicates a lot of money for research into heart disease and stroke, but it still might not be enough, a new study suggested.

<乌鸦传媒>FDA Flags Risk of Nuclear Stress Test Drugs

SILVER SPRING, Md. -- Two agents used in cardiac nuclear stress tests may carry a greater risk of heart attack and death than previously believed, the FDA said Wednesday.

<乌鸦传媒>TCT: Removing Clot During PCI Fails in NSTEMI

SAN FRANCISCO -- Aspiration thrombectomy during percutaneous coronary intervention (PCI) did not improve outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI), a randomized trial showed.

<乌鸦传媒>Add 'Shrapnel' to Workup for Lightning Strike

A shrapnel-like injury associated with a lightening strike provided a reminder for emergency physicians not to overlook the unexpected when examining patients.

<乌鸦传媒>Lab Notes: Meth May Worsen Fungal Infection

Mice injected with methamphetamine and exposed to Cryptococcus fungi showed more extensive and hard-to-eradicate infections. Also this week: an organic pesticide fights parasitic worms.

<乌鸦传媒>Zilver Stent Recalled, System May Break

Cook Medical's Zilver PTX drug-eluting stent for peripheral artery disease has been recalled because of a defect in its associated delivery system, the company and the FDA said.

<乌鸦传媒>ACC: Is Chelation Plus Vitamins a Winning Combo?

SAN FRANCISCO -- Vitamins alone won't improve outcomes for patients who've had a heart attack, but they do appear to have additive benefits when given in conjunction with controversial chelation therapy, researchers reported here.

<乌鸦传媒>Extended Apixaban Stops VTE Recurrence

ATLANTA -- Apixaban taken for an additional year after standard venous thromboembolism (VTE) treatment reduced recurrent events in a placebo-controlled trial, researchers said.

<乌鸦传媒>Cardio Notes: Sex Improves with Stenting

Opening the arteries of those with stable coronary disease also opens the door to an improved sex life. Also this week, bariatric surgery helps remodel the heart.

<乌鸦传媒>Doctors Say 45 Common Tests 'Overused'

Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project.

<乌鸦传媒>Cheney's Heart Makes Him a Million Dollar Man

Keeping former Vice President Dick Cheney's heart beating probably will cost the healthcare system at least a million dollars, cardiac transplantation experts told 乌鸦传媒.

鈥�

8